Tech Company Financing Transactions

Cardurion Pharma Funding Round

Ascenta Capital, Bain Capital Life Sciences and Bain Capital Private Equity participated in a $260 million Series B capital raise for Cardurion Pharma. The round was announced by the company on 7/16/2024.

Transaction Overview

Company Name
Announced On
7/16/2024
Transaction Type
Venture Equity
Amount
$260,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to conduct later-stage clinical trials with its two lead drug candidates, a first-in-class phosphodiesterase-9 (PDE9) inhibitor for heart failure and the first clinical-stage Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) inhibitor with broad therapeutic potential. In addition, the funding will be used to expand the cardiovascular indications for Cardurion's portfolio of drug candidates, to progress internal discovery programs and to acquire additional therapeutic assets targeting unmet needs in the cardiovascular disease area.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Lincoln St. 30th Floor
Boston, MA 02111
USA
Email Address
Overview
Cardiovascular disease is the leading cause of death worldwide in both men and women, accounting for over 17 million deaths per year, and often striking in the prime of life. This number is expected to grow to nearly 24 million by 2030.
Profile
Cardurion Pharma LinkedIn Company Profile
Social Media
Cardurion Pharma Company Twitter Account
Company News
Cardurion Pharma News
Facebook
Cardurion Pharma on Facebook
YouTube
Cardurion Pharma on YouTube

Management Team

Title
Name
Email & Social
Chairman
Michael Mendelsohn
  Michael Mendelsohn LinkedIn Profile  Michael Mendelsohn Twitter Account  Michael Mendelsohn News  Michael Mendelsohn on Facebook
Chief Executive Officer
Peter Lawrence
  Peter Lawrence LinkedIn Profile  Peter Lawrence Twitter Account  Peter Lawrence News  Peter Lawrence on Facebook
Chief Medical Officer
Howard Surks
  Howard Surks LinkedIn Profile  Howard Surks Twitter Account  Howard Surks News  Howard Surks on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2024: Asceneuron venture capital transaction
Next: 7/16/2024: Making Space venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary